Jasper Therapeutics

(NASDAQ) JSPR

Current Price$0.49

Market Cap$13.47M

Since IPO (2020)-100%

5 YearN/A

1 Year-91%

1 Month-48%

Jasper Therapeutics Financials at a Glance

Market Cap

$13.47M

Revenue (TTM)

$0.00

Net Income (TTM)

-$55.73M

EPS (TTM)

-$3.23

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$0.49

Volume

558,800

Open

$0.48

Price

$0.49

Volume

558,800

Open

$0.48

Previous Close

$0.49

Daily Range

$0.47 - $0.50

52-Week Range

$0.43 - $7.19

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$0.49

Volume

558,800

Open

$0.48

Previous Close

$0.49

Daily Range

$0.47 - $0.50

52-Week Range

$0.43 - $7.19

Estimated Earnings Date

Aug 12, 2026

JSPR News

Jasper Reports Wider Loss in Fiscal Q2

Motley Fool Markets TeamAug 13, 2025

Why Jasper Therapeutics Stock Is Jumping Today

Cory RenauerOct 13, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jasper Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jeet Mahal, MBA

Website

www.jaspertherapeutics.com

Headquarters

Redwood City, CA 94065, US

JSPR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-244%

Return on Capital

-6%

Return on Assets

-3%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.47M

Shares Outstanding

28.00M

Volume

558.80K

Avg. Volume

514.28K

Financials (TTM)

Gross Profit

-$1.06M

Operating Income

-$80.52M

EBITDA

-$79.46M

Operating Cash Flow

-$77.16M

Capital Expenditure

-$7.00K

Free Cash Flow

-$77.17M

Cash & ST Invst.

$28.69M

Total Debt

$1.24M

Jasper Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$21.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$13.47M

N/A

Market Cap/Employee

$210.55K

N/A

Employees

N/A

Net Income

-$1.17M

+94.5%

EBITDA

-$10.95M

+49.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$13.39M

-71.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$757.00K

-58.7%

Return on Assets

-2.63%

N/A

Return on Invested Capital

-5.99%

N/A

Free Cash Flow

-$14.55M

+36.3%

Operating Cash Flow

-$14.55M

+36.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$5.41-5.83%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$2.95-7.52%

CELUCelularity Inc.

CELUCelularity Inc.$0.87-12.33%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.42-3.40%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.38-2.59%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.11-10.16%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

Questions About JSPR

What is the current price of Jasper Therapeutics?

Jasper Therapeutics is trading at $0.49 per share.

What is the 52-week range for Jasper Therapeutics?

Over the past 52 weeks, Jasper Therapeutics has traded between $0.43 and $7.19.

How much debt does Jasper Therapeutics have?

As of the most recent reporting period, Jasper Therapeutics reported total debt of $757.00K.

How much cash does Jasper Therapeutics have on hand?

Jasper Therapeutics reported $14.14M in cash and cash equivalents in its most recent financial results.

What is Jasper Therapeutics’s dividend yield?

Jasper Therapeutics does not currently have a dividend yield.

Jasper Therapeutics

Jasper Therapeutics Financials at a Glance

JSPR News

Jasper Reports Wider Loss in Fiscal Q2

Why Jasper Therapeutics Stock Is Jumping Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jasper Therapeutics

JSPR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jasper Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JSPR

What is the current price of Jasper Therapeutics?

What is the 52-week range for Jasper Therapeutics?

How much debt does Jasper Therapeutics have?

How much cash does Jasper Therapeutics have on hand?

What is Jasper Therapeutics’s dividend yield?

Premium Investing Services